{"nct_id":"NCT05386680","title":"Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2023-01-12","start_date_type":"ACTUAL","primary_completion_date":"2024-11-29","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}